Effects of Resveratrol on Liver Function Tests in Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis of Randomized Controlled Trials

QR Code

Effects of Resveratrol on Liver Function Tests in Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis of Randomized Controlled Trials

Background. Some studies have shown that resveratrol may prevent, delay, or treat liver damage. This study aimed to provide up-to-date evidence regarding the effect of resveratrol on the liver enzymes (ALT & AST) in NAFLD patients. We conducted a systematic review and meta-analysis to evalua...

Full description

Saved in:

Bibliographic Details
Main Authors:	P. Ebrahimpour, M. Karamian, A. Sharifi
Format:	Article
Language:	Russian
Published:	Gastro LLC 2024-03-01
Series:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:	resveratrol non-alcoholic fatty liver disease alanine transaminase aspartate aminotransferases meta-analysis
Online Access:	https://www.gastro-j.ru/jour/article/view/921
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Asymptomatic elevation of serum aminotransferase activity: stages of diagnostic search
by: Yu. A. Tereshchenko, et al.
Published: (2014-07-01)

Morpho-functional state of the liver and changes of blood biochemical parameters in rats exposed to lead sulfide nanoparticles in the remote terms of research.
by: S. T. Omelchuk, et al.
Published: (2014-06-01)

Selected Blood Biochemical Parameters after Right and Left Nephrectomy in Clinical Practice
by: S. N. Liashchenko, et al.
Published: (2024-10-01)

Elevation of transaminases. What if not the liver?
by: I. V. Sharkova
Published: (2024-04-01)

Association between herbicide exposure and liver enzyme levels in a middle-aged and elderly population
by: Weiya LI, et al.
Published: (2025-06-01)

PULMONARY AND LIVER DAMAGE DURING TREATMENT WITH ACETAMINOPHEN (PARACETAMOL)
by: L. I. Dvoretski, et al.
Published: (2016-08-01)

The effect of obesity and Insulin Resistance on Liver Enzymes in Type2 Diabetes Mellitus
by: Baghdad Science Journal
Published: (2015-09-01)

Daily dynamics of blood transaminase under normal light conditions and modified under the influence of alcoholic beverages
by: Tamara Ismailovna Dzhandarova, et al.
Published: (2022-09-01)

Approbation of a Model of Fat Liver Disease Induced by Orotic Acid
by: V. V. Kovanskov, et al.
Published: (2022-11-01)

Prognostic Value of the AST/ALT Ratio in Patients with Septic Shock: A Prospective, Multicenter, Registry-Based Observational Study
by: Sungwoo Choi, et al.
Published: (2025-07-01)

Association between triglyceride–glucose index and liver enzymes in adults with metabolic syndrome: a retrospective cross-sectional study
by: Raju Rana, et al.
Published: (2025-12-01)

Prognostic value of elevated transaminase levels as predictors of adverse outcomes in patients with acute myocardial infarction
by: T. H. Hoang, et al.
Published: (2024-10-01)

Biochemical blood counts in the application of fish oil preparations in conditions of intense physical activity
by: E. A. Knyazeva, et al.
Published: (2025-06-01)

Local biocompatibility and biochemical profile of hepatic cytolysis in subcutaneous implantation of polylactide matrices
by: E. A. Ivanova, et al.
Published: (2023-01-01)

Hepatoprotection by L-Ornithine L-Aspartate in Non-Alcoholic Fatty Liver Disease
by: Roger F. Butterworth, et al.
Published: (2019-03-01)

Association between Serum Uric Acid and Non-Alcoholic Fatty Liver Disease: A Meta-Analysis
by: Guntur Darmawan, et al.
Published: (2017-08-01)

Association between Serum Uric Acid and Non-Alcoholic Fatty Liver Disease: A Meta-Analysis
by: Guntur Darmawan, et al.
Published: (2017-08-01)

Nomogram for evaluating obvious liver inflammation in treatment-naïve HBeAg positive chronic hepatitis B virus infection patients with normal ALT
by: Lu Zhang, et al.
Published: (2023-12-01)

Reactive Oxygen Species as Key Molecules in the Pathogenesis of Alcoholic Fatty Liver Disease and Nonalcoholic Fatty Liver Disease: Future Perspectives
by: Zhiqing Zhang, et al.
Published: (2025-06-01)

REDUCING THE INCIDENCE OF HEMORRHAGIC FATTY LIVER SYNDROME IN LAYING HENS FED RAISIN JUICE BYPRODUCTS AND RESVERATROL AND THEIR IMPACT ON NRF2 AND TNFΑ GENE EXPRESSION AND ANTIOXIDANT STATUS
by: O. K. Attallah, et al.
Published: (2025-06-01)

Improvement of non-alcoholic fatty liver disease treatment
by: P. I. Seliverstov, et al.
Published: (2014-10-01)

Practical Aspects of Clinical Manifestations, Pathogenesis and Therapy of Alcoholic Liver Disease and Non-alcoholic Fatty Liver Disease: Expert Opinion
by: V. V. Tsukanov, et al.
Published: (2023-11-01)

Sex-specific effect of dietary fatty acids on non-alcoholic fatty liver disease
by: Jianhua Chen, et al.
Published: (2025-07-01)

Draft Clinical Guidelines for the Diagnosis and Treatment of Metabolically Associated Fatty Liver Disease in Children (Non-Alcoholic Fatty Liver Disease)
by: Alexander A. Baranov, et al.
Published: (2025-05-01)

Application of glycyrrhizinic acid in treatment of patients with alcoholic liver disease
by: I. G. Nikitin, et al.
Published: (2009-02-01)

SCHEME FOR COMBINED USE OF STATINS AND URSODEOXYCHOLIC ACID IN PATIENTS WITH A HIGH RISK OF CARDIOVASCULAR EVENTS AND CONCOMITANT NON-ALCOHOLIC FATTY LIVER DISEASE: PROBLEMS OF PRACTICAL APPLICATION
by: S. N. Bel'diev
Published: (2017-03-01)

Liver Cirrhosis as the Outcome of Non-Alcoholic Fatty Liver Disease Associated with PNPLA3 Gene RS738409 Polymorphism
by: I. G. Nikitin, et al.
Published: (2020-03-01)

Fast food consumption and risk of non-alcoholic fatty liver disease: a systematic review and meta-analysis
by: Jinke He, et al.
Published: (2025-07-01)

Non-alcoholic fatty liver disease and cardiovascular pathology: pathogenetic parallels
by: G. Yu. Knorring, et al.
Published: (2024-08-01)

Liver and Nutrition. An Optimal Diet for Non-Alcoholic Fatty Liver Disease
by: M. V. Mayevskaya, et al.
Published: (2018-11-01)

Effect of resveratrol on key signaling pathways including SIRT1/AMPK/Smad3/TGF-β and miRNA-141 related to NAFLD in an animal model
by: Sahar Yarahmadi, et al.
Published: (2025-05-01)

NON-ALCOHOLIC FATTY LIVER DISEASE AND CARDIOVASCULAR RISK: SCIENTIFIC PROBLEM STATE
by: O. M. Drapkina, et al.
Published: (2017-11-01)

Metabolic and Genetic Determinants of Lipid Metabolism Disruption in Non-Alcoholic Fatty Liver Disease
by: O. Yu. Kytikova, et al.
Published: (2020-05-01)

NON-ALCOHOLIC FATTY LIVER DISEASE OUTCOMES FUNNEL
by: D. V. Blinov
Published: (2015-12-01)

The effect of non-alcoholic fatty liver disease on the development of cardiovascular diseases
by: N. A. Starodubtseva, et al.
Published: (2025-03-01)

Cognitive dysfunction in patients with non-alcoholic fatty liver disease
by: S. A. Smakotina, et al.
Published: (2025-06-01)

Epidemiologic features of non-alcoholic fatty liver disease in Russia
by: O. M. Drapkina, et al.
Published: (2014-10-01)

Genetic aspects of non-alcoholic fatty liver disease development
by: V. A. Akhmedov, et al.
Published: (2021-06-01)

Pathogenic role of lipids in non-alcoholic fatty liver disease
by: Yu. O. Shulpekova
Published: (2012-02-01)

Intrahepatic Cholestasis in Non-Alcoholic Fatty Liver Disease: Pathogenesis and Role of Ademetionine in Treatment
by: Ye. N. Shirokova
Published: (2023-08-01)